Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women
- Movano Health and ams OSRAM collaboration brings high-quality data to the forefront of consumer health devices
- Evie Ring is a personalized solution designed specifically for women, providing medical-grade data measurement of critical vitals for an on-demand understanding of overall health
- ams OSRAM's PPG sensor solution achieves an increased total radiant intensity of more than 40 percent over the previous generation products and offers a significantly larger photodetector surface area for more sensitive and accurate readings
- Evie Ring is a 2024 CES Innovation Award Honoree in the Wearables category
- Movano Health successfully launched the Evie Ring on November 20, 2023, and showcased the solution at CES Unveiled
- None.
Insights
With the integration of ams OSRAM's advanced PPG sensor technology into Movano Health's Evie Ring, there is a clear indication of the burgeoning market for personalized health tech, especially devices tailored for women. The collaboration not only enhances the product's capability but also taps into the growing trend of consumers seeking health monitoring devices that offer medical-grade data.
From a market perspective, this partnership could position Movano Health as a frontrunner in the female health tech segment. The Evie Ring's unique selling proposition—a wearable specifically designed for women—could capture a significant share of the market, considering the lack of competition in gender-specific health devices. Additionally, the CES Innovation Award serves as a credibility marker that may boost consumer trust and adoption rates.
The success of the Evie Ring could have a ripple effect on the stock market, potentially increasing investor confidence in Movano Health. The company's ability to innovate and penetrate niche markets is a positive sign for its growth trajectory and could influence its stock valuation positively.
The technological advancements highlighted by the collaboration between Movano Health and ams OSRAM could represent a significant step forward in the field of biometric monitoring. The PPG sensor solution's ability to deliver more sensitive and accurate readings is crucial for the early detection and monitoring of health conditions. Medical-grade data measurement capabilities in consumer devices may bridge gaps in healthcare accessibility and empower individuals with actionable health insights.
Furthermore, the Evie Ring's design considerations for women's physiology—smaller fingers and lower perfusion—demonstrate a targeted approach to product development in health technology. This focus on specificity could lead to improved outcomes for female users and may set a new standard for personal health monitoring devices, potentially influencing future research and development in the sector.
The financial implications of Movano Health's partnership with ams OSRAM and the subsequent launch of the Evie Ring are multifaceted. The initial market response, as seen with the product's CES Innovation Award, suggests a positive reception that could translate into strong sales performance. The collaboration leverages ams OSRAM's established reputation in sensor technology, which may reduce the risk profile associated with the product's technological aspects.
Investors should monitor the sales figures and market penetration of the Evie Ring closely, as these will provide tangible metrics for evaluating Movano Health's performance. The strategic focus on a niche market—health tech for women—may allow for premium pricing strategies and higher profit margins. Long-term, the success of this product could pave the way for additional investment in R&D and expansion into new markets, potentially enhancing Movano Health's financial stability and growth prospects.
With the goal to bring high-quality data to the forefront of consumer health devices, Movano Health´s female-first wearable, the Evie Ring, is a personalized solution designed specifically for women that provides medical-grade data measurement of critical vitals for an on-demand understanding of overall health. The Evie Ring is a 2024 CES Innovation Award Honoree in the Wearables category.
ams OSRAM´s complete PPG sensor solution, which consists of the Optical Front End (OFE) SFH 7014c emitter and SFH 2705 detector technology coupled with the company´s Analog Front End (AFE) AS7057, is able to achieve an increased total radiant intensity of more than 40 percent over the previous generation products and its photodetector has a surface area that is significantly larger than competing products. This allows for much more sensitive and accurate readings, overcoming the challenges that all biometric monitoring devices face: accurate detection of micro modulations of small light signals, results of scattering and absorption in tissue and amount of light emitted by LEDs, which strongly affect system performance. This supports Evie's objective to deliver a device uniquely built for women's fingers.
"Our world-class engineers have designed the Evie Ring for women who typically have smaller fingers, and lower perfusion. In order to ensure a best-in-class experience when it comes to collecting data from the finger, we needed a cutting edge solution on both the optical and analog side. The ams OSRAM solution enables us to meet the unique needs of our consumer," said Michael Leabman, Founder and CTO of Movano Health. "Ensuring an accurate signal is tantamount to delivering trusted results and actionable insights."
"Our accurate optical sensors and advanced capabilities of our analog front end enable a miniaturized yet highly accurate PPG (Photoplethysmography) system. Through our carefully engineered technologies, we are able to offer a complete PPG sensor solution comprised of the industry´s smallest analog front end sensor AS7057 with market leading compact multi-emitter SFH 7014c and SFH 2705 for precise health monitoring. Movano Heath's outstanding design and the appeal of a female-first solution make them an ideal partner for revolutionary health monitoring in wearable devices," explained Dr. Markus Arzberger, Senior Director CSA IOS Automotive & Vital Signs (CSA IOS AVS), ams OSRAM.
Movano Health successfully launched the Evie Ring on November 20, 2023, and showcased the solution at CES Unveiled this past weekend. The Evie Ring can be purchased exclusively at www.eviering.com
About Movano Health
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health is developing a suite of purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. Featuring modern form factors, Movano Health's devices capture a comprehensive picture of a person's vital health information and uniquely translate the data into personalized and intelligent insights that empower consumers to live healthier and more balanced lives. Movano Health's end-to-end solutions will soon enable consumers and their healthcare professionals to utilize daily medical-grade data as a tool to proactively monitor and manage health outcomes. For more information on Movano Health, visit https://movanohealth.com/.
Forward Looking Statements
This press release contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs, or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially from those anticipated. Therefore, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding plans with respect to commercial launch of the Evie Ring; planned cost-cutting initiatives; anticipated FDA clearance for the Evie Ring and other products in development; expected future operating results; product development and features, product releases, clinical trials and regulatory initiatives; our strategies, positioning and expectations for future events or performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption "Risk Factors." Any forward-looking statement in this release speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
View original content to download multimedia:https://www.prnewswire.com/news-releases/movano-health-and-ams-osram-collaborate-to-deliver-accurate-lifestyle-monitoring-solutions-for-women-302029285.html
SOURCE Movano
FAQ
What is the collaboration between Movano Health and ams OSRAM?
What is the Evie Ring designed for?
What is ams OSRAM's PPG sensor solution able to achieve?
What award did the Evie Ring receive?
When was the Evie Ring launched?
